medigraphic.com

2017, Number 1

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2017; 55 (1)

Effect of the DiabetIMSS program on cardiovascular risk, blood pressure and HDL cholesterol in patients with metabolic syndrome

Mendoza-Romo MÁ, Montes-Acuña JF, Zavala-Cruz GG, Nieva-de Jesús RN, Ramírez-Arreola MC, Andrade-Rodríguez HJ

Language: Spanish
References: 31
Page: 32-39
PDF size: 285.46 Kb.


ABSTRACT

Background: The aim of this paper is to evaluate the effect of the DiabetIMSS program on cardiovascular risk, blood pressure and HDL cholesterol in patients with metabolic syndrome.
Methods: Quasi-experimental intervention study. Non-probabilistic convenience sampling. 35 subjects in the educational strategy one year were included. The following variables were collected: age, gender, smoking, total cholesterol, HDL cholesterol, systolic and diastolic blood pressure; cardiovascular risk calculator based on Framingham is calculated. Descriptive and inferential statistical percentages with Student t test was used.
Results: There was an increase in the proportion of subjects increased their subsequent figures HDL cholesterol intervention, there by generating an increase of protective factor (p ‹ 0.05). Because of the blood pressure a marked improvement in all ranges of blood pressure (p ‹ 0.05) was presented.
Conclusions: The educational strategy for the control of diabetic patients presented a favorable performance in HDL-cholesterol and blood pressure, reducing the risk of cardiovascular patients.


REFERENCES

  1. Cabrera-Pivaral CE, González-Pérez G, Vega-López MG, Centeno-López M. Efectos de una intervención educativa sobre los niveles plasmáticos de LDL-colesterol en diabéticos tipo 2. Salud Pública de México. 2001;43(6);556-562.

  2. Cabrera-Rode E, Cálix-Iglesias WD, Stusser-Iglesias BI, Parlá-Sardiñas J, Álvarez-Álvarez A, Olano- Justiniani R et al. Relación de la resistencia a la insulina con el riesgo cardiovascular, según diferentes tablas y factores de riesgo cardiovascular en sujetos sobrepesos y obesos. Revista Cubana de Endocrinología. 2013;24(2):136-152.

  3. Zuñiga-Ramírez MG, Villarreal-Ríos E, Vargas-Daza ER, Galicia-Rodríguez L, Martínez-González L, Cervantes-Becerra RG. Perfil de uso de los servicios del módulo DiabetIMSS por pacientes con diabetes mellitus 2. Rev Enferm Inst Mex Seguro Soc. 2013;21(2):79-84.

  4. León-Mazón. DiabetIMSS. Eficacia del programa de educación en diabetes en los parámetros clínicos y bioquímicos. Rev Med Inst Mex Seguro Soc. 2012;51(1):74-9.

  5. Flores-López ME, Velázquez-Tlapanco N, Camacho- Calderón. Control metabólico, estado nutricional y presión arterial de diabéticos tipo 2. Eficacia de una estrategia educativa. Rev Med Inst Mex Seguro Soc. 2008;46(3):301-310.

  6. Rondanelli R, Rondanelli SR. Prevention of cardiovascular disease in older adults. Rev Med Clin Condes. 2012;23(6):724-731.

  7. Cabré JJ, Martín F, Costa B, Piñor JL, Llor JL, Ortega Y et al. Metabolic Syndrome as a Cardiovascular Disease Risk Factor: Patients Evaluated in Primary Care. BMC Public Health. 2008;8:251.

  8. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.

  9. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. Third National Health and Nutrition Examination Survey (NHANES III). National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes. 2003,52:1210-1214.

  10. National Cholesterol Education Program. National Heart, Lung, and Blood Institute. National Institutes of Health. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). 2002. EUA. 1-284.

  11. Chiang P. Cardio-metabolic risk factors and prehypertension in persons without diabetes, hypertension, and cardiovascular disease. BMC Public Health. 2013;13:730.

  12. Laitinen D, Manthena S. Impact of Change in High- Density Lipoprotein Cholesterol from Baseline on Risk for Major Cardiovascular Events. Adv Ther. 2010;27(4):233-244.

  13. Navarro-Santamaría V, Zabala-Letona A, Gómez- Zorita S, Portillo-Baquedano M. Metabolismo del colesterol: bases actualizadas. Revista Española de Obesidad. 2009;7(6):360-384.

  14. Chen HC. Molecular mechanisms of sterol absorption. J Nutr. 2001;131:2603-5.

  15. Jaquish C. The Framingham Heart Study, on its way to becoming the gold standard for Cardiovascular Genetic Epidemiology? BMC Medical Genetics. 2007;8(63):1-3.

  16. Hingorani AD, Vallance P. A simple computer program for guiding management of cardiovascular risk factors and prescribing. BMJ. 1999;31:101-105.

  17. Gutiérrez JP, Rivera-Dommarco J, Shamah-Levy T, Villalpando-Hernández S, Franco A, Cuevas-Nasu L et al. Encuesta Nacional de Salud y Nutrición 2012. Resultados Nacionales. Cuernavaca, México: Instituto Nacional de Salud Pública. 2012.

  18. Chamnan P, Simmons R, Sharp J, Griffin J, Wareham J. Cardiovascular risk assessment scores for people with diabetes: a systematic review. Diabetologia. 2009;52:2001-2014.

  19. Savitha MR, Sandeep B. The study of lipid profile, diet and other cardiovascular risk factors in children born to parents having premature ischemic heart disease. Indian Journal of Community Medicine. 2011;36:4.

  20. Matched-Pair A. Randomized CT- Effect of Adding Systematic Family History Enquiry to Cardiovascular Disease Risk Assessment in Primary Care. Annals of Internal Medicine. 2012;156:4.

  21. Bertomeu V, Fácila L, González-Juanatey JR, Cea- Calvo L, Aznare J, Mazón P et al. Control de las cifras de presión arterial en los pacientes hipertensos con hipertrofia ventricular: estudio VIIDA. Rev Esp Cardiol. 2007;60:1257-63.

  22. Ndindjock R, Gedeon J, Mendis S, Paccaud F, Bovet P. Potential impact of single risk factor versus total risk management for the prevention of cardiovascular events in Seychelles. Bull World Health Organ. 2011;89:286-295.

  23. Hosseini SS. The relationship between body mass index and cardiovascular risk factors in inactive male students. Annals of Biological Research. 2011;2(6):130-134.

  24. Pocock SJ, McCormack V, Gueyffier F, Boutitie F, Fagard RH, Boissel JP. A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials. BMJ. 2001;323:75-81.

  25. Salinas-Martínez AF, Muñoz-Moreno AR, Barraza- de León E, Villarreal-Ríos GM, Núñez-Rocha, Garza-Elizondo ME. Necesidades de Salud del diabético usuario del primer nivel de atención. Salud Publica Mex. 2001;43(4):324-335.

  26. Fu-Espinosa M, Trujillo-Olivera LE. Trastorno depresivo y aspectos relacionados con beneficiarios DiabetIMSS. Rev Med Inst Mex Seguro Soc. 2013;51(1):80-5.

  27. Sheridan S, Pignone M, Mulrow C. Framinghambased tools to calculate the global risk of coronary heart disease. A systematic review of tools for clinicians. J Gen Intern Med. 2003;18(12):1039-1052.

  28. Grau M, Marugat J. Funciones de riesgo en la prevención primaria de las enfermedades cardiovasculares. Rev Esp Cardiol. 2008;61:404-16.

  29. Ávila-Burgos L, Cahuana-Hurtado L, González-Domínguez D, Aracena-Genao B, Montañez-Hernández JC, Serván-Mori EE, Rivera-Peña G. Cuentas en diabetes mellitus, enfermedades cardiovasculares y obesidad, México 2006. Ciudad de México/ Cuernavaca, México: Instituto Nacional de Salud Pública, 2009.

  30. Frenk J, Frejka T, Bobadilla J, Stern C, Lozano R, Sepúlveda J, Mauco J. La Transición Epidemiológica en América Latina. Bol of Sanit Panam. 1991;111(6):485-496.

  31. Mendoza-Romo MA, Velasco-Chávez JF. Impact of an educational institutional program in the control of the diabetic patient. Rev Med Inst Mex Seguro Soc. 2013;51(3):8-11.




2020     |     www.medigraphic.com